MPM: Peninsula biotech startup uncloaks with $94M from Lilly and others to target cancer

Getting drugs aimed at degrading disease-causing proteins to the right target has been an issue. Companies like Firefly Bio think they can get those drugs to ride along with antibodies to knock out cancers.